Enhancement of peroxynitrite-induced apoptosis in PC12 cells by fibroblast growth factor-1 and nerve growth factor requires p21Ras activation and is suppressed by Bcl-2.
Extracellular trophic factors can regulate whether cells subjected to oxidative stress will survive to proliferate or else undergo cell death. We have previously shown that about 35% of undifferentiated PC12 cells undergo apoptosis 18 h after exposure to peroxynitrite and that pretreatment with nerve growth factor (NGF) protects PC12 cells through activation of phosphatidylinositol (PI) 3-kinase. In contrast, pretreatment with acidic fibroblast growth factor (FGF-1) approximately doubled apoptosis. We report here that NGF added immediately after peroxynitrite treatment no longer protected against apoptosis, but instead enhanced apoptosis to the same extent as FGF. We further investigated which signaling pathways were involved in increasing the level of apoptosis. Overexpression of Bcl-2 blocked the increased apoptosis caused by NGF and FGF-1, but Bcl-2 did not prevent the induction of apoptosis by peroxynitrite alone. The increase in apoptosis caused by the trophic factors was also blocked by the expression of a dominant negative p21Ras mutant. Activation of PI 3-kinase by NGF pretreatment completely protected against both the enhanced apoptosis induced by FGF-1 pretreatment and NGF posttreatment and the apoptosis induced by peroxynitrite alone. Our results indicate that the enhancement of peroxynitrite-induced apoptosis caused by NGF and FGF-1 is dependent on the stimulation of a proapoptotic pathway involving p21Ras that can be suppressed by Bcl-2.
Spear
N
N
Department of Anesthesiology, University of Alabama at Birmingham, Birmingham, Alabama, 35233-6810, USA. Nathan.Spear@cc.uab.edu
Estévez
A G
AG
Johnson
G V
GV
Bredesen
D E
DE
Thompson
J A
JA
Beckman
J S
JS
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D004357:Drug Synergism; D016220:Fibroblast Growth Factor 1 / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009154:Mutation; D009414:Nerve Growth Factors / Q000494:pharmacology*; D009566:Nitrates / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D016716:PC12 Cells; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis / Q000502:physiology*; D016283:Proto-Oncogene Proteins p21(ras) / Q000187:drug effects / Q000378:metabolism*; D051381:Rats
D009414:Nerve Growth Factors; D009566:Nitrates; D019253:Proto-Oncogene Proteins c-bcl-2; D016220:Fibroblast Growth Factor 1; C039642:peroxynitric acid; D016283:Proto-Oncogene Proteins p21(ras)